Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen

Christopher M. Booth; Joseph L. Pater; Paul E. Goss

doi:10.1002/cncr.22613

Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen

Cancer ◽

10.1002/cncr.22613 ◽

2007 ◽

Vol 109 (9) ◽

pp. 1927-1928

Author(s):

Christopher M. Booth ◽

Joseph L. Pater ◽

Paul E. Goss

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy

Download Full-text

Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4296-3 ◽

2017 ◽

Vol 164 (3) ◽

pp. 737-743 ◽

Cited By ~ 4

Author(s):

Andy Göbel ◽

Jan D. Kuhlmann ◽

Theresa Link ◽

Pauline Wimberger ◽

Andrew J. Browne ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Serum Levels ◽

Inhibitor Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Wnt Inhibitor ◽

Dickkopf 1

Download Full-text

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients

Journal of Bone Oncology ◽

10.1016/j.jbo.2019.100237 ◽

2019 ◽

Vol 16 ◽

pp. 100237

Author(s):

Andy Göbel ◽

Jan D. Kuhlmann ◽

Theresa Link ◽

Pauline Wimberger ◽

Cornelia Link-Rachner ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Plasma Levels ◽

Inhibitor Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Semaphorin 4D

Download Full-text

Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy

PsycEXTRA Dataset ◽

10.1037/e684272011-001 ◽

2011 ◽

Author(s):

Jacqueline R. Weaver ◽

Shauna M. Stark ◽

Karineh T. Shaverdi ◽

Stacie Jeter ◽

Jane Zorzi ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Neuropsychological Functioning ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy

Download Full-text

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy

Current Oncology ◽

10.3747/co.v18i6.909 ◽

2011 ◽

Vol 18 (6) ◽

Cited By ~ 8

Author(s):

A. Robidoux ◽

E. Rich ◽

N.J. Bureau ◽

S. Mader ◽

D. Laperrière ◽

...

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Musculoskeletal Pain ◽

Postmenopausal Breast Cancer ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Prospective Pilot Study

Download Full-text

Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy?

Clinical Oncology ◽

10.1016/j.clon.2012.06.009 ◽

2012 ◽

Vol 24 (8) ◽

pp. e128-e129 ◽

Cited By ~ 6

Author(s):

C.E. Simmons ◽

I. Kuchuk ◽

O.C. Freedman ◽

T. Colgan ◽

A. Dodd ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Urogenital Atrophy

Download Full-text

Study of Neurobehavioral Symptoms and Impairments in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy.

10.1158/0008-5472.sabcs-09-4084 ◽

2009 ◽

Author(s):

J. Weaver ◽

S. Stark ◽

K. Shahverdi ◽

S. Jeter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Neurobehavioral Symptoms

Download Full-text

Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry

Clinical Breast Cancer ◽

10.1016/j.clbc.2014.02.003 ◽

2014 ◽

Vol 14 (5) ◽

pp. 365-370 ◽

Cited By ~ 6

Author(s):

Sofia Battisti ◽

Francesco Maria Guida ◽

Federica Coppa ◽

Donata M. Vaccaro ◽

Daniele Santini ◽

...

Keyword(s):

Breast Cancer ◽

Computed Tomography ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Fat Distribution ◽

Abdominal Fat ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Computed Tomography Volumetry

Download Full-text

FLT-PET (Fluorothymidine) and Ki-67 to measure effects of a short course of aromatase inhibitor therapy in ER+ breast cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e22161 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e22161-e22161

Author(s):

Hannah M. Linden ◽

Lanell Peterson ◽

Brenda F. Kurland ◽

Alena Novakova ◽

Andrew Shields ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Ki 67 ◽

Aromatase Inhibitor Therapy ◽

Flt Pet ◽

Short Course

Download Full-text

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1611-2 ◽

2011 ◽

Vol 130 (2) ◽

pp. 569-577 ◽

Cited By ~ 21

Author(s):

Lisa Gallicchio ◽

Ryan MacDonald ◽

Bethany Wood ◽

Errol Rushovich ◽

Kathy J. Helzlsouer

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Musculoskeletal Symptoms ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy

Download Full-text

Cardiovascular Health among Black and White Breast Cancer Patients Initiating Aromatase Inhibitor Therapy

The Breast Journal ◽

10.1111/tbj.12709 ◽

2016 ◽

Vol 23 (2) ◽

pp. 206-209 ◽

Cited By ~ 4

Author(s):

Lisa Gallicchio ◽

Carla Calhoun ◽

David Riseberg ◽

Kathy Helzlsouer

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Cardiovascular Health ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Black And White

Download Full-text